MedPath

STANFORD UNIVERSITY

STANFORD UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1885-11-11
Employees
10K
Market Cap
-
Website
http://www.stanford.edu

Pivotal Response Group Treatment for Parents of Young Children With Autism

Not Applicable
Completed
Conditions
Autistic Disorder
Interventions
Behavioral: Parent Education Group (PEG)
Behavioral: Pivotal Response Training (PRT)
First Posted Date
2013-06-20
Last Posted Date
2019-08-16
Lead Sponsor
Stanford University
Target Recruit Count
53
Registration Number
NCT01881750
Locations
🇺🇸

Stanford University School of Medicine, Stanford, California, United States

Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF

Completed
Conditions
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
First Posted Date
2013-06-10
Last Posted Date
2022-08-29
Lead Sponsor
Stanford University
Target Recruit Count
40
Registration Number
NCT01874223
Locations
🇺🇸

Stanford University Medical Center, Chest Clinic, Stanford, California, United States

Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer

Phase 2
Terminated
Conditions
Male Breast Cancer
Recurrent Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IIIC Breast Cancer
Interventions
Drug: lapatinib ditosylate
Radiation: radiation therapy
Other: laboratory biomarker analysis
First Posted Date
2013-06-04
Last Posted Date
2017-06-26
Lead Sponsor
Stanford University
Target Recruit Count
7
Registration Number
NCT01868503
Locations
🇺🇸

Stanford University Cancer Institute, Stanford, California, United States

Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services

Not Applicable
Completed
Conditions
Legally Induced Abortion Without Mention of Complication
Interventions
First Posted Date
2013-05-27
Last Posted Date
2024-02-14
Lead Sponsor
Stanford University
Target Recruit Count
80
Registration Number
NCT01862991
Locations
🇺🇸

Stanford University Medical Center, Stanford, California, United States

🇺🇸

Santa Clara Valley Medical Center, San Jose, California, United States

Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls

Not Applicable
Completed
Conditions
Anal Squamous Intraepithelial Lesion (ASIL)
HPV DNA
Interventions
Procedure: Anal Pap smear and HPV DNA testing
First Posted Date
2013-05-23
Last Posted Date
2013-10-01
Lead Sponsor
Stanford University
Target Recruit Count
310
Registration Number
NCT01860963
Locations
🇺🇸

Stanford Digestive Health Center, Stanford, California, United States

Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala

Phase 2
Terminated
Conditions
Retinoblastoma
Interventions
First Posted Date
2013-05-20
Last Posted Date
2017-01-30
Lead Sponsor
Stanford University
Target Recruit Count
3
Registration Number
NCT01857752
Locations
🇬🇹

Unidad Nacional de Oncologia Pediatrica, Guatemala, Guatemala

A National Study of the Chronic Disease Self-Management Program

Not Applicable
Completed
Conditions
Chronic Disease
Diabetes Mellitus, Type 2
Interventions
Behavioral: Chronic Disease Self-Management Workshop
First Posted Date
2013-05-03
Last Posted Date
2013-05-03
Lead Sponsor
Stanford University
Target Recruit Count
1170
Registration Number
NCT01845857
Locations
🇺🇸

Stanford University School of Medicine, Stanford, California, United States

Treatment for Insomnia During Pregnancy

Not Applicable
Completed
Conditions
Sleep Initiation and Maintenance Disorders
Interventions
Behavioral: Cognitive Behavioral Therapy for Insomnia
Behavioral: Arousal Based Therapy for Insomnia
First Posted Date
2013-05-03
Last Posted Date
2018-07-23
Lead Sponsor
Stanford University
Target Recruit Count
194
Registration Number
NCT01846585
Locations
🇺🇸

Stanford University, Palo Alto, California, United States

Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID)

Not Applicable
Completed
Conditions
Acute Mountain Sickness
Interventions
Device: Control
Device: Theravent
First Posted Date
2013-04-30
Last Posted Date
2018-12-13
Lead Sponsor
Stanford University
Target Recruit Count
219
Registration Number
NCT01842906
Locations
🇳🇵

Nepal, Pheriche & Dingboche, Khumbu, Nepal

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 2
Withdrawn
Conditions
Adult Acute Monoblastic Leukemia (M5a)
Adult Acute Myeloblastic Leukemia With Maturation (M2)
Adult Acute Megakaryoblastic Leukemia (M7)
Adult Acute Minimally Differentiated Myeloid Leukemia (M0)
Adult Acute Myelomonocytic Leukemia (M4)
Adult Erythroleukemia (M6a)
Adult Pure Erythroid Leukemia (M6b)
Recurrent Adult Acute Myeloid Leukemia
Adult Acute Monocytic Leukemia (M5b)
Adult Acute Myeloblastic Leukemia Without Maturation (M1)
Interventions
Drug: arsenic trioxide
Other: laboratory biomarker analysis
First Posted Date
2013-04-18
Last Posted Date
2018-05-21
Lead Sponsor
Stanford University
Registration Number
NCT01835288
© Copyright 2025. All Rights Reserved by MedPath